Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jan 2, 2020 at 9:55 AM EST

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization…

$Why This Refractory Angina Treatment Could Be a Big Hit$

Chris Lange | Dec 31, 2019 at 10:10 AM EST

Why This Refractory Angina Treatment Could Be a Big Hit

Neovasc shares nearly doubled on Tuesday after the firm announced the submission of an application to the FDA for its…

Chris Lange | Dec 30, 2019 at 1:10 PM EST

Is It Over for This Huntington’s Disease Clinical Trial?

Wave Life Sciences shares dropped sharply to start out the week after the company announced topline data from its ongoing…

Chris Lange | Dec 30, 2019 at 12:30 PM EST

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about…

Chris Lange | Dec 30, 2019 at 10:20 AM EST

Why This aPAP Treatment Is a Big Hit

Savara shares more than doubled on Monday after the firm announced that the FDA has granted Breakthrough Therapy designation for…

Chris Lange | Dec 30, 2019 at 9:50 AM EST

AstraZeneca’s FDA Nod Could Be Big

AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.

Chris Lange | Dec 27, 2019 at 1:00 PM EST

Why This Uriniary Tract Infection Trial Could Be Huge

Iterum Therapeutics shares more than doubled on Friday after the firm announced that it had completed the enrollment of its…

Chris Lange | Dec 27, 2019 at 8:50 AM EST

Why This Osteoarthritis Treatment Is Making Waves

Flexion Therapeutics shares popped on Friday after the company announced that the FDA has approved a supplemental New Drug Application…

Chris Lange | Dec 26, 2019 at 3:19 PM EST

The Top Healthy Living ETFs of 2019

Eating a nutritious and well-balanced diet, exercising regularly and abstaining from bad habits like smoking greatly increase one’s odds of…

Chris Lange | Dec 26, 2019 at 12:05 PM EST

Could This Breast Cancer Study Be the Next Big Thing?

Immunomedics shares made a handy gain on Thursday after the company announced that the FDA has accepted its Biologics License…

Chris Lange | Dec 26, 2019 at 10:00 AM EST

Why This Cancer Study Is Crushing Spectrum Pharma

Spectrum Pharma shares were halved on Thursday after the firm provided an update on its midstage cancer study some updates…

Paul Ausick | Dec 26, 2019 at 9:46 AM EST

A Third of Adolescents Make Risky Lifestyle Choices

A new analysis of data collected from more than 300,000 adolescents worldwide show that more than a third engage in…

Chris Lange | Dec 26, 2019 at 8:55 AM EST

Big Pharma Short Sellers Get Selective

The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Dec 26, 2019 at 8:40 AM EST

Major Biotechs See Rising Short Interest

The December 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Dec 24, 2019 at 10:05 AM EST

Will Microbot Medical’s Robotic Surgery System Be a Big Hit?

Microbot Medical shares made a massive gain on Tuesday after the company revealed its Liberty system, which would be the…

1 … 73 74 75 76 77 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Why This Refractory Angina Treatment Could Be a Big Hit

Is It Over for This Huntington’s Disease Clinical Trial?

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Why This aPAP Treatment Is a Big Hit

AstraZeneca’s FDA Nod Could Be Big

Why This Uriniary Tract Infection Trial Could Be Huge

Why This Osteoarthritis Treatment Is Making Waves

The Top Healthy Living ETFs of 2019

Could This Breast Cancer Study Be the Next Big Thing?

Why This Cancer Study Is Crushing Spectrum Pharma

A Third of Adolescents Make Risky Lifestyle Choices

Big Pharma Short Sellers Get Selective

Major Biotechs See Rising Short Interest

Will Microbot Medical’s Robotic Surgery System Be a Big Hit?

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Why This Refractory Angina Treatment Could Be a Big Hit

Is It Over for This Huntington’s Disease Clinical Trial?

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Why This aPAP Treatment Is a Big Hit

AstraZeneca’s FDA Nod Could Be Big

Why This Uriniary Tract Infection Trial Could Be Huge

Why This Osteoarthritis Treatment Is Making Waves

The Top Healthy Living ETFs of 2019

Could This Breast Cancer Study Be the Next Big Thing?

Why This Cancer Study Is Crushing Spectrum Pharma

A Third of Adolescents Make Risky Lifestyle Choices

Big Pharma Short Sellers Get Selective

Major Biotechs See Rising Short Interest

Will Microbot Medical’s Robotic Surgery System Be a Big Hit?

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up